IIC
BIIB icon

Ironwood Investment Counsel’s Biogen BIIB Stock Holding History

Ironwood Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,548
Closed -$766K – 154
2018
Q4 		$766K Sell
2,548
-78
-3% -$24.9K 0.34% 73
2018
Q3 		$927K Buy
+2,626
New +$904K 0.36% 70

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ironwood Investment Counsel's BIIB Position: Q1 2019 in Review

Ironwood Investment Counsel sold out of Biogen (BIIB) in Q1 2019, closing a stake of 2,548 shares — an estimated $766K sold.

Ironwood Investment Counsel first reported a position in BIIB in Q3 2018 and held it in 2 quarters. The position peaked at $927K in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Ironwood Investment Counsel reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Ironwood Investment Counsel sold 2,548 Biogen shares in Q1 2019, an estimated $766K.
  • Ironwood Investment Counsel first reported a position in Biogen in Q3 2018 and held it in 2 quarters.
  • Ironwood Investment Counsel's Biogen position peaked at $927K in Q3 2018.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Ironwood Investment Counsel's 13F filing for Q1 2019, filed 1 May 2019.